Peptomyc S.L. secures 4.2 Million Euros in Series A led by Alta Life Sciences

Laura Soucek (Peptomyc), Montserrat Vendrell (Alta Life Science) and Marie-Eve Beaulieu (Peptomyc).


We are very pleased to announce the closure of a Series A financing of 4.2 million euros, led by Alta Life Sciences Spain I FCR, and we welcome the opportunity to work with an amazing team of experts in the development and commercialization of […]

06 / 09 / 17|

Peptomyc selected by L’Econòmic as a potential unicorn

A panel of experts and investors chose the 9 business projects – tech and biotech start-ups – that they believe are most likely to be the first Catalan unicorn. The term is used to describe a start-up that attains a valuation of 1 billion dollars. Very few projects reach this level and so far none […]

13 / 07 / 17|

Peptomyc receives 212000 euros from the Spanish Centre for the Development of Industrial Technology (CDTI)


This latest award from the CDTI and Spanish Ministry Mineco represents substantial further support for Peptomyc’s mission and will help in the development of OMO-101 and its derivative OMO-103. The project is titled “Pre-clinical development of Myc-inhibiting peptides to treat cancer” (“Desarrollo pre-clínico de péptidos inhibidores de Myc para el tratamiento de cáncer”).


The award is from […]

03 / 05 / 17|

Peptomyc receives further support from Spanish Ministry Mineco


In their latest successful application for funding, Peptomyc has earned 15000 euros from the CDTI in the Spanish Ministry of Economy, Industry and Competitiveness (Mineco). APC grants (Ayudas a la Preparación de Propuestas Comunitarias) are designed to promote the participation of Spanish companies in 3 specific Calls for research and innovation that are financed by […]

25 / 04 / 17|

Peptomyc wins Startup Slam competition at BIO-Europe Spring® Barcelona

Neruda Scott (Johnson & Johnson), Bauke Anninga (Innovation Forum), Laura Soucek (Peptomyc) and Emma Kohring (Johnson & Johnson).


Panel of expert judges selects winner from 14 short-listed European start-ups that showed greatest potential for transformative healthcare solutions

Startup Slam sponsor and co-host Johnson & Johnson Innovation recognizes high caliber of entries selected to compete for prestigious award


25 / 03 / 17|

Peptomyc is proud to join CatalonioBio


CataloniaBio is an association of companies in the health and life sciences arena in Catalonia. Its mission is to represent and support companies interested in promoting a strategic, innovative cluster, as well as helping to define the framework for sector-wide actions and industrial policies established at a national and European level.

The association was created in 2006 by a group of entrepreneurs […]

24 / 03 / 17|

Peptomyc receives 850K € from Spanish Mineco and European Commission joint fund


The project is financed by the Spanish Ministry of Economy and Competition (Ministerio de Economía y Competitividad), and co-financed by the European Regional Development Fund (ERDF; known as FEDER in Spain). It corresponds to the 2016 Challenge-Collaboration (Retos-Colaboración) call of the Programa Estatal de Investigación, Desarrollo e Innovación Orientada a los Retos de la Sociedad, […]

30 / 11 / 16|

Peptomyc wins prize at EIT Health Summit

Barcelona 23-24th November 2016
Around 350 participants from 19 countries joined the EIT Health Summit on 23 and 24 November 2016 in Barcelona. During the meeting, participants enjoyed networking opportunities and the chance to learn more about EIT Health activities and involvement opportunities.

A highlight of the event was the Business Plan Aggregator Competition. 21 start-ups pitched their […]

23 / 11 / 16|

Peptomyc completed a successful and constructive Briefing Meeting with the Innovation Task Force of the European Medicines Agency (EMA) at their headquarters in London, U.K.

Such Briefing Meetings provide a forum for early dialogue covering regulatory, technical and scientific issues arising from the development of innovative medicines. The scientific informal brainstorming discussions are led by experts from the Agency network, working parties and committees, and complement and reinforce existing formal procedures.

19 / 09 / 16|

Peptomyc completes Seed Funding of €1M

Funds will help company reach preclinical validation for lead candidate in glioblastoma – an aggressive and lethal brain tumor – and in other cancer indications.


27 / 04 / 16|